These results indicated that NOP14 exerted its functions on melanoma cells through the Wnt/β-catenin signaling pathway, and suggested that targeting of NOP14 may constitute a novel therapeutic approach for treating patients with melanoma or abnormally activated Wnt/β-catenin signaling pathway. The gene discussed is NOP14; the disease is melanoma.